Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV Biotech Investing
Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS in Latest ICER Draft Evidence Report Biotech Investing
Lexaria to Present and Meet with Investors One-on-One at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 Biotech Investing
/R E P E A T -- Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067/ Biotech Investing
Gilead's Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI Biotech Investing
HempFusion Is the Top Performing Topical CBD Brand at Major Food-Drug Mass Retailer Biotech Investing
